XLRN - Acceleron Pharma Inc - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Biological Products, (No Diagnostic Substances) - XLRN (1280600)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
36 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2019-09-10
XLRNVeness Adam MVP, GC, Sec.S - Sale$45.20-82416,101-5%-$37,241
2019-09-10
XLRNKumar RavindraSVP, Chief Scientific OfficerS - Sale$45.24-3,38986,986-4%-$153,318
2019-09-10
XLRNQuisel John DEVP, Chief Business OfficerS - Sale$45.23-3,58459,158-6%-$162,104
2019-09-10
XLRNMcLaughlin Kevin FSVP, CFO, TreasurerS - Sale$45.30-8,00022,279-26%-$362,400
2019-09-10
XLRNDable Habib JCEO, PresS - Sale$45.23-5,62570,883-7%-$254,412
2019-08-09
XLRNVeness Adam MVP, GC, Sec.S - Sale$45.00-3,26816,925-16%-$147,060
2019-07-16
XLRNVeness Adam MVP, GC, Sec.S - Sale$40.71-53820,193-3%-$21,902
DM
2019-06-26
XLRNGeorge JeanDirS - Sale+OE$39.79-37,5003,750-91%-$1,492,242
2019-06-14
XLRNZakrzewski Joseph SDirP - Purchase$38.05+5,00012,750+65%+$190,250
2019-04-09
XLRNKumar RavindraSVP, Chief Scientific OfficerS - Sale$44.64-3,62290,375-4%-$161,671
2019-04-09
XLRNQuisel John DEVP, CBO, SecretaryS - Sale$44.64-3,62253,834-6%-$161,671
2019-04-09
XLRNMcLaughlin Kevin FSVP, CFO, TreasurerS - Sale$44.62-12,00030,279-28%-$535,405
2019-04-09
XLRNDable Habib JCEO, PresS - Sale$44.60-7,46076,508-9%-$332,748
2019-04-02
XLRNMcLaughlin Kevin FSVP, CFO, TreasurerS - Sale$48.02-64842,279-2%-$31,117
2019-01-18
XLRNCelgene Corp /de/10%P - Purchase$43.00+706,2066,824,685+12%+$30,366,858
2019-01-02
XLRNKumar RavindraSVP, Chief Scientific OfficerS - Sale$42.94-5,78890,147-6%-$248,546
2019-01-02
XLRNQuisel John DEVP, CBO, SecretaryS - Sale$42.83-5,94252,656-10%-$254,490
2019-01-02
XLRNMcLaughlin Kevin FSVP, CFO, TreasurerS - Sale$42.80-5,71238,227-13%-$244,494
2019-01-03
XLRNDable Habib JCEO, PresS - Sale$43.41-1,95766,268-3%-$84,961
2018-12-04
XLRNDable Habib JCEO, PresS - Sale$52.99-12,67568,225-16%-$671,610
D
2018-08-30
XLRNMcLaughlin Kevin FSVP, CFO, TreasurerS - Sale+OE$54.00-12,50043,939-22%-$675,000
D
2018-06-29
XLRNMcLaughlin Kevin FSVP, CFO, TreasurerS - Sale+OE$48.00-25,00043,939-36%-$1,200,000
2018-04-03
XLRNRovaldi ChristopherSVP, Program Mgmt, OpsS - Sale$38.40-3,50025,858-12%-$134,395
2018-04-03
XLRNKumar RavindraSVP, Chief Scientific OfficerS - Sale$38.41-1,20395,935-1%-$46,205
2018-04-03
XLRNQuisel John DSVP, Corp. Dev., GC, Sec.S - Sale$38.40-1,20456,598-2%-$46,232
2018-04-03
XLRNSherman Matthew LEVP, Chief Medical OfficerS - Sale$38.43-4,60077,267-6%-$176,772
2018-04-03
XLRNMcLaughlin Kevin FSVP, CFO, TreasurerS - Sale$38.45-4,00043,939-8%-$153,792
D
2018-03-06
XLRNPops Richard FDirS - Sale+OE$41.42-37,50031,250-55%-$1,553,094
D
2018-01-12
XLRNRovaldi ChristopherSVP, Program Mgmt, OpsS - Sale+OE$45.00-11,00024,701-31%-$495,000
M
2018-01-02
XLRNRovaldi ChristopherSVP, Program Mgmt, OpsS - Sale$42.42-2,26624,701-8%-$96,134
2018-01-02
XLRNKumar RavindraSVP, Chief Scientific OfficerS - Sale$42.41-4,30092,675-4%-$182,363
2018-01-02
XLRNQuisel John DSVP, Corp. Dev., GC, Sec.S - Sale$42.42-4,33352,977-8%-$183,806
DM
2018-01-02
XLRNMcLaughlin Kevin FSVP, CFO, TreasurerS - Sale+OE$42.89-19,00042,801-31%-$814,848
2018-01-03
XLRNSherman Matthew LEVP, Chief Medical OfficerS - Sale$42.71-4,63381,867-5%-$197,868
2017-12-15
XLRNGeorge JeanDirS - Sale$35.73-105,1221,250-99%-$3,756,009
2017-09-25
XLRNCelgene Corp /de/10%P - Purchase$37.00+745,5926,118,479+14%+$27,586,904
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top